GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » EV-to-FCF

MedMen Enterprises (MedMen Enterprises) EV-to-FCF : -11.69 (As of Jun. 05, 2024)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, MedMen Enterprises's Enterprise Value is $371.7 Mil. MedMen Enterprises's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2023 was $-31.8 Mil. Therefore, MedMen Enterprises's EV-to-FCF for today is -11.69.

The historical rank and industry rank for MedMen Enterprises's EV-to-FCF or its related term are showing as below:

MMNFQ's EV-to-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 22.555
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), MedMen Enterprises's stock price is $1.0E-6. MedMen Enterprises's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 was $-0.100. Therefore, MedMen Enterprises's PE Ratio for today is At Loss.


MedMen Enterprises EV-to-FCF Historical Data

The historical data trend for MedMen Enterprises's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises EV-to-FCF Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.71 -1.78 -1.51 -2.38 0.09

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.32 0.09 1.36 3.27 2.82

Competitive Comparison of MedMen Enterprises's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's EV-to-FCF falls into.



MedMen Enterprises EV-to-FCF Calculation

MedMen Enterprises's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=371.696/-31.783
=-11.69

MedMen Enterprises's current Enterprise Value is $371.7 Mil.
MedMen Enterprises's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-31.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedMen Enterprises  (OTCPK:MMNFQ) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

MedMen Enterprises's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.0E-6/-0.100
=At Loss

MedMen Enterprises's share price for today is $1.0E-6.
MedMen Enterprises's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.100.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


MedMen Enterprises EV-to-FCF Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises (MedMen Enterprises) Business Description

Traded in Other Exchanges
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.